dopamine beta hydroxylase deficiency
|
0.710 |
Biomarker
|
disease |
BEFREE |
Norepinephrine deficiency is caused by combined abnormal mRNA processing and defective protein trafficking of dopamine beta-hydroxylase.
|
21209083 |
2011 |
dopamine beta hydroxylase deficiency
|
0.710 |
Biomarker
|
disease |
MGD |
Leptin regulation of bone resorption by the sympathetic nervous system and CART.
|
15724149 |
2005 |
dopamine beta hydroxylase deficiency
|
0.710 |
Biomarker
|
disease |
MGD |
Noradrenaline is essential for mouse fetal development.
|
7715704 |
1995 |
dopamine beta hydroxylase deficiency
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
dopamine beta hydroxylase deficiency
|
0.710 |
Biomarker
|
disease |
CTD_human |
|
|
|
ORTHOSTATIC HYPOTENSION 1
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Hyperinsulinemia and Insulin Resistance in Dopamine β-Hydroxylase Deficiency.
|
27778639 |
2017 |
ORTHOSTATIC HYPOTENSION 1
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
Hyperinsulinemia and Insulin Resistance in Dopamine β-Hydroxylase Deficiency.
|
27778639 |
2017 |
ORTHOSTATIC HYPOTENSION 1
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
The International Working Group on Neurotransmitter related Disorders (iNTD): A worldwide research project focused on primary and secondary neurotransmitter disorders.
|
27830117 |
2016 |
ORTHOSTATIC HYPOTENSION 1
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
ORTHOSTATIC HYPOTENSION 1
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
Norepinephrine deficiency is caused by combined abnormal mRNA processing and defective protein trafficking of dopamine beta-hydroxylase.
|
21209083 |
2011 |
ORTHOSTATIC HYPOTENSION 1
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
Neurocognitive function in dopamine-β-hydroxylase deficiency.
|
21471955 |
2011 |
ORTHOSTATIC HYPOTENSION 1
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
DBH gene variants that cause low plasma dopamine beta hydroxylase with or without a severe orthostatic syndrome.
|
15060114 |
2004 |
ORTHOSTATIC HYPOTENSION 1
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
A revised allele frequency estimate and haplotype analysis of the DBH deficiency mutation IVS1+2T --> C in African- and European-Americans.
|
14598346 |
2003 |
ORTHOSTATIC HYPOTENSION 1
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
Mutations in the dopamine beta-hydroxylase gene are associated with human norepinephrine deficiency.
|
11857564 |
2002 |
ORTHOSTATIC HYPOTENSION 1
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in the dopamine beta-hydroxylase gene are associated with human norepinephrine deficiency.
|
11857564 |
2002 |
Mental Depression
|
0.530 |
Biomarker
|
disease |
PSYGENET |
The aim of this association study in a large multicenter sample of alcohol-dependent individuals and controls is to investigate the role of DBH SNPs and haplotypes in AD risk and associated phenotypes (AD with MD or SA).
|
23906995 |
2013 |
Mental Depression
|
0.530 |
GeneticVariation
|
disease |
BEFREE |
The aim of this association study in a large multicenter sample of alcohol-dependent individuals and controls is to investigate the role of DBH SNPs and haplotypes in AD risk and associated phenotypes (AD with MD or SA).
|
23906995 |
2013 |
Mental Depression
|
0.530 |
Biomarker
|
disease |
PSYGENET |
Molecular genetic studies point to potential risk loci of psychotic depression shared with schizoaffective disorder (1q42, 22q11, 19p13), depression, bipolar disorder, and schizophrenia (6p, 8p22, 10p13-12, 10p14, 13q13-14, 13q32, 18p, 22q11-13) and several vulnerability genes possibly contributing to an increased risk of psychotic symptoms in depression (eg, BDNF, DBH, DTNBP1, DRD2, DRD4, GSK-3beta, MAO-A).
|
23512949 |
2013 |
Mental Depression
|
0.530 |
Biomarker
|
disease |
PSYGENET |
Tyrosine-hydroxylase (TH) and dopamine-beta-hydroxylase (DBH) mRNA levels were decreased both in right and left atria, while phenylethanolamine N-methyltransferase (PNMT) mRNAs were increased in left atria and both ventricles of depression model rats.
|
23305027 |
2012 |
Mental Depression
|
0.530 |
Biomarker
|
disease |
PSYGENET |
Genotype-controlled analysis of serum dopamine β-hydroxylase activity in civilian post-traumatic stress disorder.
|
20621148 |
2010 |
Mental Depression
|
0.530 |
Biomarker
|
disease |
RGD |
Degeneration of the locus ceruleus noradrenergic neurons in the stress-induced depression of rats.
|
19120095 |
2008 |
Mental Depression
|
0.530 |
Biomarker
|
disease |
PSYGENET |
The strength of the association of DBH genotype with depression essentially remained unchanged after correction for other variables in a multivariate model.
|
17698206 |
2008 |
Mental Depression
|
0.530 |
GeneticVariation
|
disease |
BEFREE |
The strength of the association of DBH genotype with depression essentially remained unchanged after correction for other variables in a multivariate model.
|
17698206 |
2008 |
Mental Depression
|
0.530 |
Biomarker
|
disease |
BEFREE |
In addition, since the activity of plasma and cerebrospinal fluid (CSF) dopamine beta-hydroxylase (DBH) is genetically determined, the co-occurrence of delusional depression and Parkinsonism in this patient may be related to a common underlying genetic defect that expresses itself biochemically by reduced cerebral NE metabolism.
|
8083026 |
1993 |
Alcoholic Intoxication, Chronic
|
0.400 |
Biomarker
|
disease |
BEFREE |
DBH is also involved in the pathophysiology of alcoholism.
|
24201835 |
2014 |